+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Thrombosis of sirolimus-eluting coronary stent in the postanesthesia care unit



Thrombosis of sirolimus-eluting coronary stent in the postanesthesia care unit



Anesthesia and Analgesia 101(4): 971-973



A 44-yr-old woman with a drug-eluting coronary stent placement two weeks before surgery suffered a myocardial infarction in the postanesthesia care unit immediately after hysterectomy. She had missed only one dose of aspirin and clopidogrel preoperatively. Early recognition of subacute stent thrombosis and urgent percutaneous coronary intervention probably prevented her death. In this case report, we highlight perioperative coronary stent issues and discuss their implications.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012693422

Download citation: RISBibTeXText

PMID: 16192504

DOI: 10.1213/01.ane.0000175821.42010.9f


Related references

Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Jacc. Cardiovascular Interventions 2(12): 1199-1207, 2009

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. Lancet 380(9851): 1396-1405, 2012

Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Jacc. Cardiovascular Interventions 4(5): 543-550, 2011

A new polymer-free drug-eluting stent with nanocarriers eluting sirolimus from stent-plus-balloon compared with bare-metal stent and with biolimus A9 eluting stent in porcine coronary arteries. Cardiovascular Diagnosis and Therapy 5(2): 113-121, 2015

Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial. Circulation. Cardiovascular Interventions 7(3): 343-354, 2014

Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial. Journal of the American College of Cardiology 47(7): 1350-1355, 2006

Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial. Journal of the American College of Cardiology 53(17): 1488-1497, 2009

Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 112(14): 2175-2183, 2005

Risk of stent thrombosis after sirolimus or paclitaxel eluting coronary stent implantation. British Journal of Clinical Pharmacology 64(1): 110-112, 2007

A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated by EveroLimus-Eluting Stent) trial. Eurointervention 6(1): 112-116, 2010

Coronary aneurysm and very late stent thrombosis formation associated with sirolimus-eluting stent implantation. Chinese Medical Journal 122(24): 3097-3098, 2009

Late stent thrombosis associated with coronary aneurysm formation after sirolimus-eluting stent implantation. Journal of Invasive Cardiology 19(4): E96-E98, 2007

Coronary artery aneurysms and late stent thrombosis after sirolimus-eluting stent placement. Coronary Artery Disease 27(4): 337-340, 2016

Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction - Comparison between Sirolimus-Eluting Stent and paclitaxel-eluting Stent. International Heart Journal 48(5): 553-567, 2007

Right coronary artery 'diverticulosis' 4 years after sirolimus-eluting stent implantation associated with very late stent thrombosis. Heart 99(21): 1627, 2013